<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0038">
 <label>38</label>
 <element-citation publication-type="journal" id="sbref0032">
  <person-group person-group-type="author">
   <name>
    <surname>Slater</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>FDA accepts IND for NK cell therapy CYNK-001 to treat patients with COVID-19</article-title>
  <source>Cancer Network</source>
  <year>April 3, 2020</year>
  <ext-link ext-link-type="uri" xlink:href="https://www.cancernetwork.com/immuno-oncology/fda-accepts-ind-nk-cell-therapy-cynk-001-treat-patients-covid-19" id="interref0007" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.cancernetwork.com/immuno-oncology/fda-accepts-ind-nk-cell-therapy-cynk-001-treat-patients-covid-19</ext-link>
  <comment>accessed 23.5.2020</comment>
 </element-citation>
</ref>
